Pfizer CEO: No Drug Price Pledges Made in Talks with Trump Administration

Drug Price Discussions with US Government

• 🤝 Pfizer CEO Albert Bourla stated that meetings with the Trump administration regarding lowering US drug prices have occurred.
• 🚫 No commitments have been made by drug companies during these discussions.
• 🗓️ The meetings took place at a Goldman Sachs healthcare conference.

Trump Administration's Executive Order

• 📜 President Trump issued an executive order aimed at directing drug makers to lower drug prices.
• 🎯 The order seeks to align US prices with those paid in other countries, specifically targeting a "most favored nation" price.
• ⏳ The administration was expected to set these price targets within 30 days.

Potential Impact and Company Response

• 📉 The Department of Health and Human Services anticipated US drug makers would set prices at the lowest rate paid by other high-income countries.
• ❓ Bourla expressed uncertainty about what companies would hear in 30 days, describing the meetings as cordial but lacking substantive discussion.
• ⚠️ Analysts and legal experts have noted the difficulty in implementing the proposed policy.
• 📈 Bourla is hopeful that US pressure on European countries to pay more could lead to increased prices in those regions.
• ⚠️ If the US implements price controls, Pfizer might consider not making drugs available for government reimbursement in some countries if prices do not rise there.